» Articles » PMID: 2377625

K-sam, an Amplified Gene in Stomach Cancer, is a Member of the Heparin-binding Growth Factor Receptor Genes

Overview
Specialty Science
Date 1990 Aug 1
PMID 2377625
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

DNA fragments amplified in a stomach cancer-derived cell line, KATO-III, were previously identified by the in-gel DNA renaturation method, and a 0.2-kilobase-pair fragment of the amplified sequence was subsequently cloned. By genomic walking, a portion of the exon of the gene flanking this 0.2-kilobase-pair fragment was cloned, and the gene was designated as K-sam (KATO-III cell-derived stomach cancer amplified gene). The K-sam cDNAs, corresponding to the 3.5-kilobase K-sam mRNA, were cloned from the KATO-III cells. Sequence analysis revealed that this gene coded for 682 amino acid residues that satisfied the characteristics of the receptor tyrosine kinase. The K-sam gene had significant homologies with bek, FLG, and chicken basic fibroblast growth factor receptor gene. The K-sam gene was amplified in KATO-III cells with the major transcript of 3.5-kilobases in size. This gene was also expressed in some other stomach cancer cells, a small cell lung cancer, and germ cell tumors.

Citing Articles

Receptor Tyrosine Kinases Amplified in Diffuse-Type Gastric Carcinoma: Potential Targeted Therapies and Novel Downstream Effectors.

Yamaguchi H, Nagamura Y, Miyazaki M Cancers (Basel). 2022; 14(15).

PMID: 35954414 PMC: 9367326. DOI: 10.3390/cancers14153750.


Transferrin receptor 1 promotes the fibroblast growth factor receptor-mediated oncogenic potential of diffused-type gastric cancer.

Shirakihara T, Yamaguchi H, Kondo T, Yashiro M, Sakai R Oncogene. 2022; 41(18):2587-2596.

PMID: 35338344 DOI: 10.1038/s41388-022-02270-5.


Preclinical characterization of bemarituzumab, an anti-FGFR2b antibody for the treatment of cancer.

Xiang H, Chan A, Ahene A, Bellovin D, Deng R, Hsu A MAbs. 2021; 13(1):1981202.

PMID: 34719330 PMC: 8565817. DOI: 10.1080/19420862.2021.1981202.


SHP2 as a Potential Therapeutic Target in Diffuse-Type Gastric Carcinoma Addicted to Receptor Tyrosine Kinase Signaling.

Nagamura Y, Miyazaki M, Nagano Y, Tomiyama A, Ohki R, Yanagihara K Cancers (Basel). 2021; 13(17).

PMID: 34503119 PMC: 8430696. DOI: 10.3390/cancers13174309.


Fibroblast Growth Factor Receptors (FGFRs) and Noncanonical Partners in Cancer Signaling.

Ferguson H, Smith M, Francavilla C Cells. 2021; 10(5).

PMID: 34068954 PMC: 8156822. DOI: 10.3390/cells10051201.


References
1.
Deng G, Lu Y, Chen S, Miao J, Lu G, Li H . Activated c-Ha-ras oncogene with a guanine to thymine transversion at the twelfth codon in a human stomach cancer cell line. Cancer Res. 1987; 47(12):3195-8. View

2.
Roninson I, Abelson H, Housman D, Howell N, Varshavsky A . Amplification of specific DNA sequences correlates with multi-drug resistance in Chinese hamster cells. Nature. 1984; 309(5969):626-8. DOI: 10.1038/309626a0. View

3.
Merkel D, Dressler L, McGuire W . Flow cytometry, cellular DNA content, and prognosis in human malignancy. J Clin Oncol. 1987; 5(10):1690-703. DOI: 10.1200/JCO.1987.5.10.1690. View

4.
Roninson I . Use of in-gel DNA renaturation for detection and cloning of amplified genes. Methods Enzymol. 1987; 151:332-71. DOI: 10.1016/s0076-6879(87)51028-x. View

5.
Saiki R, Gelfand D, Stoffel S, Scharf S, Higuchi R, Horn G . Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988; 239(4839):487-91. DOI: 10.1126/science.2448875. View